Flow Cell

A cationic polymer hydrogel in a flow cell substrate addresses inefficiencies in DNA library generation by attracting and confining fragments, improving sequencing efficiency and cluster density for effective nucleic acid reconstruction.

JP7581206B2Active Publication Date: 2024-11-12ILLUMINA INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2021537728
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-08-01
Filing Date
2020-07-22
Publication Date
2024-11-12
Estimated Expiration
2040-07-22

AI Technical Summary

Technical Problem

Existing methods for generating libraries of fragmented and tagged DNA molecules from double-stranded DNA (dsDNA) are inefficient in achieving spatial confinement and uniform seeding, leading to random binding and reduced sequencing efficiency.

Method used

A cationic polymer hydrogel is incorporated into a flow cell substrate, featuring positively charged moieties that attract and spatially confine library fragments, enhancing seeding efficiency by reducing random binding and improving cluster density.

Benefits of technology

The method improves seeding efficiency, reduces library input requirements, and enhances spatial cloud identification, allowing for better reconstruction of nucleic acid sequences through bioinformatic stitching of short reads.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581206000015
    Figure 0007581206000015
  • Figure 0007581206000016
    Figure 0007581206000016
  • Figure 0007581206000017
    Figure 0007581206000017
Patent Text Reader

Abstract

An example flow cell includes a substrate and a cationic polymer hydrogel on the substrate. The cationic polymer hydrogel includes cationic moieties i) incorporated into the monomer units of the initial polymer hydrogel or ii) attached to the monomer units of the initial polymer hydrogel via a linker. The flow cell further includes amplification primers attached to the cationic polymer hydrogel.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application claims the benefit of U.S. Provisional Application No. 62 / 881,597, filed August 1, 2019, the contents of which are incorporated herein by reference in their entirety. [Background technology]

[0002] There are various methods and applications in which it is desired to generate libraries of fragmented and tagged deoxyribonucleic acid (DNA) molecules from double-stranded DNA (dsDNA) target molecules. Often, the purpose is to generate smaller DNA molecules (e.g., DNA fragments) from larger dsDNA molecules for use as templates in DNA sequencing reactions. The templates may allow for short read lengths to be obtained. During data analysis, overlapping short sequence reads can be aligned to reconstruct longer nucleic acid sequences. In some cases, a pre-sequencing step (e.g., barcoding of specific nucleic acid molecules) can be used to simplify data analysis.

[0003] (Introduction) A first aspect disclosed herein is a flow cell comprising a substrate, a cationic polymer hydrogel on the substrate, the cationic polymer hydrogel comprising cationic moieties i) incorporated into the monomer units of the initial polymer hydrogel or ii) attached via a linker to the monomer units of the initial polymer hydrogel, and an amplification primer bound to the cationic polymer hydrogel.

[0004] In one example of the first aspect, the monomer unit is N-(5-bromoacetamidylpentyl)acrylamide and the cationic moiety is a phosphonium cation, the phosphonium cation replacing the bromine of N-(5-bromoacetamidylpentyl)acrylamide. In one example, the phosphonium cation is selected from the group consisting of tris(hydroxymethyl)phosphonium cation, tris(hydroxypropyl)phosphonium cation, tetrakis(hydroxymethyl)phosphonium cation, and tris(2-carboxyethyl)phosphonium cation.

[0005] In another example of the first embodiment, i) the monomeric unit comprises a terminal azide group and the linker comprises an alkyne group, or ii) the monomeric unit comprises a terminal alkyne group and the linker comprises an azide group. In one example, the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In another example, the monomeric unit is N-(5-azidoacetamidylpentyl)acrylamide and the cationic moiety is a N,N,N-trimethylethanolammonium cation. In yet another example, the linker further comprises a cleavable disulfide bond, a photocleavable bond, a cleavable phosphodiester bond, or a combination thereof.

[0006] In yet another example of the first aspect, the monomer unit is N-(5-azidoacetamidylpentyl)acrylamide, the linker comprises a terminal alkyne group and a terminal bromine, and the cationic moiety is a phosphonium cation replacing the terminal bromine.

[0007] In an example of the first embodiment, the substrate comprises a plurality of recesses separated by intervening regions, and the cationic polymer hydrogel is disposed within each of the recesses. In one example, the substrate further comprises a plurality of chambers, and a subset of the plurality of recesses is located within the perimeter of each of the plurality of chambers.

[0008] It should be understood that any of the features of the flow cells disclosed herein may be combined together in any desired manner and / or configuration to achieve the advantages described in this disclosure, including, for example, positive charges for attracting and spatially confining library fragments.

[0009] A second aspect disclosed herein includes introducing a fluid including positively charged moieties into a flow cell including an initial polymer hydrogel having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups, and an amplification primer attached to the initial polymer hydrogel, and incubating the initial polymer hydrogel in the fluid at a temperature for a period of time, thereby forming a cationic polymer hydrogel including cationic moieties.

[0010] In one example of the second aspect, the positively charged moieties replace negatively charged atoms of the initial polymer hydrogel. In one example, the surface moieties are negatively charged atoms, the negatively charged atoms are bromine, and the positively charged moieties are selected from the group consisting of tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine, and tris(2-carboxyethyl)phosphine. In one example, the fluid further comprises a buffer having a pH in the range of 6 to 12. In one example, the temperature is in the range of about 18° C. to about 65° C., and the time is in the range of about 1.5 minutes to about 5 minutes.

[0011] In another example of the second embodiment, the surface moiety is an azide group or an alkyne group, and the positively charged moiety is covalently attached to the surface moiety via a linker. In one example, the surface moiety is an azide group, the linker is an alkyne group, and the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In one example, the surface moiety is an alkyne group, the linker is an azide group, and the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In one example, the compound comprises a positively charged moiety attached to a linker, and the compound is propargylcholine bromide. In one example, the fluid comprises water. In one example, the temperature ranges from about 18° C. to about 60° C., and the time ranges from about 30 minutes to about 12 hours. In one example, the method further comprises adding a catalyst, a ligand, and a reducing agent to a flow cell containing the fluid.

[0012] It should be understood that any of the features of this method may be combined together in any desired manner. Further, it should be understood that any combination of the features of this method and / or flow cell features may be used together and / or in combination with any of the examples disclosed herein to achieve the advantages described in this disclosure including, for example, positive charges to attract and spatially confine library fragments.

[0013] A third aspect disclosed herein is a kit comprising a substrate, an initial polymer hydrogel disposed on the substrate, the initial polymer hydrogel having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups, an amplification primer attached to the initial polymer hydrogel, and a fluid comprising positively charged moieties that interact or react with the surface moieties to form a cationic polymer hydrogel comprising cationic moieties.

[0014] It should be understood that any of the features of the kits may be combined in any desired manner. Further, it should be understood that any combination of features of the kits and / or methods, and / or features of the flow cell may be used together and / or in combination with any of the examples disclosed herein to achieve the advantages described in this disclosure, including, for example, positive charges to attract and spatially confine library fragments. [Brief description of the drawings]

[0015] Features of examples of the present disclosure will become apparent by reference to the following detailed description and the drawings in which like reference numbers correspond to similar, but perhaps not identical, components. For the sake of brevity, reference numbers or features having previously described functions may or may not be described in conjunction with the other drawings in which they appear.

[0016] [Figure 1] FIG. 1 is a flow diagram illustrating an example of a method disclosed herein.

[0017] [Figure 2A] 2 is a semi-schematic perspective view illustrating together the method of FIG. 1, showing a portion of a flow cell containing an initial polymer hydrogel. [Figure 2B] FIG. 2 is a semi-schematic perspective view illustrating together the method of FIG. 1, showing a portion of a flow cell containing a polymeric hydrogel of a positively charged (cationic) polymer hydrogel.

[0018] [Diagram 3] 1 is a chemical formula illustrating the formation of an example of a cationic polymer hydrogel.

[0019] [Figure 4] 1 is a chemical formula illustrating the formation of another example of a cationic polymer hydrogel.

[0020] [Figure 5A]13A-13C are chemical formulas illustrating the formation of yet another example of a cationic polymer hydrogel. [Figure 5B] 13A-13C are chemical formulas illustrating the formation of yet another example of a cationic polymer hydrogel.

[0021] [Figure 6] FIG. 2 is a semi-schematic perspective view of a portion of another example of a flow cell disclosed herein.

[0022] [Figure 7] FIG. 13 is a semi-schematic perspective view of a portion of yet another example of a flow cell as disclosed herein.

[0023] [Figure 8A] 1 is a schematic diagram of different examples of conjugates disclosed herein. [Figure 8B] 1 is a schematic diagram of different examples of conjugates disclosed herein. [Figure 8C] 1 is a schematic diagram of different examples of conjugates disclosed herein.

[0024] [Figure 9A] 13 is an inverted photomicrograph image of released DNA library fragments on a comparative flow cell containing untreated hydrogel in a single lane of a glass substrate (original dark areas of the image are inverted to white, and original light areas of the image are inverted to black).

[0025] [Figure 9B] FIG. 9B is a schematic diagram of the interaction of released DNA library fragments with untreated hydrogel in the comparison flow cell of FIG. 9A.

[0026] [Figure 10A] FIG. 1 is an inverted photomicrograph image of released DNA library fragments on an exemplary flow cell comprising tris(hydroxypropyl)-phosphine treated hydrogel in a single lane of a glass substrate (original dark areas of the image are inverted to white, original light areas of the image are inverted to black).

[0027] [Figure 10B] FIG. 10B is a schematic diagram of the interaction of released DNA library fragments with a processing hydrogel in the exemplary flow cell of FIG. 10A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0028] An example of a flow cell disclosed herein includes a positive charge on the surface of a polymer hydrogel and an amplification primer, which serves to attract and spatially confine the library fragments released from the support that are then introduced into the flow cell.

[0029] Library fragments are single-stranded, similarly sized (e.g., <1000 bp) deoxyribonucleic acid (DNA) pieces of a larger nucleic acid sample, or complementary deoxyribonucleic acid (cDNA) pieces derived from ribonucleic acid (RNA) pieces of a larger nucleic acid sample, with adapters attached to each end. The positively charged hydrogel surface attracts the negatively charged library fragments released from the individual carriers. This reduces random binding of the library fragments across the flow cell surface, reducing or preventing the library fragments from seeding at the side walls of the flow cell. Thus, library seeding efficiency is improved.

[0030] Improving seeding efficiency can have many advantages and benefits. For example, improved seeding efficiency can reduce library input requirements. In another example, improved seeding efficiency can result in at least substantially homogenized cluster density. During sequencing, individual clusters generate "spatial clouds" of fluorescent signals as nucleotides are incorporated into the respective template strands of the clusters. Confinement of the clusters can at least reduce crosstalk and / or overlap of the spatial clouds, and can also improve discrimination of the spatial clouds. Furthermore, since the reads obtained from any individual cluster may be generated from the same sample, the reads can be used to reconstruct the sample by bioinformatically stitching together short reads.

[0031] An example method disclosed herein introduces positive charges onto the surface of an initial polymer hydrogel while maintaining the sequencing compatibility of the surface.

[0032] definition

[0033] Terms used herein shall be understood to have their ordinary meaning in the relevant art unless otherwise specified. Some terms used herein and their meanings are described below.

[0034] As used herein, the singular forms "a," "an," and "the" refer to both the singular and the plural unless the context clearly dictates otherwise. As used herein, the term "comprising" is synonymous with "including," "containing," or "characterized by" and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.

[0035] References throughout this specification to "one example," "another example," "an example," etc. mean that a particular element (e.g., a feature, structure, composition, configuration, and / or characteristic) described in connection with an example is included in at least one example described herein, and may or may not be present in other examples. Moreover, unless the context clearly dictates otherwise, it should be understood that the described elements with respect to any example may be combined in any suitable manner in the various examples.

[0036] As used throughout this disclosure, including the claims, the terms "substantially" and "about" are used to describe and account for small variations, such as those due to variations in processing, etc. For example, these terms can refer to ±5% or less from the stated value, such as ±2% or less from the stated value, ±1% or less from the stated value, ±0.5% or less from the stated value, ±0.2% or less from the stated value, ±0.1% or less from the stated value, or ±0.05% or less from the stated value.

[0037] Adapter: A linear oligonucleotide sequence that can be fused to a nucleic acid molecule, for example, by ligation or tagmentation. In some examples, the adapter is at least substantially non-complementary to the 3' or 5' end of any target sequence introduced into the flow cell. Suitable adapter lengths can range from about 10 nucleotides to about 100 nucleotides, or from about 12 nucleotides to about 60 nucleotides, or from about 15 nucleotides to about 50 nucleotides. The adapter can include any combination of nucleotides and / or nucleic acids. In some examples, the adapter includes one or more cleavable groups at one or more positions. In some examples, the adapter can include a sequence complementary to at least a portion of a primer, for example, a primer that includes a universal nucleotide sequence (e.g., a P5 or P7 sequence). In some examples, the adapter can include an index or barcode sequence that aids in downstream error correction, identification, or sequencing. The index can be unique to a sample or source of the nucleic acid molecule (e.g., fragment). In some examples, the adapter can include a sequencing primer sequence or a sequencing binding site. A combination of different adapters can be incorporated into a nucleic acid molecule, such as a DNA fragment.

[0038] Capture site: a portion of a flow cell surface that is modified with physical modifications and / or chemical properties that allow for localization of either a complex or a sample. In one example, a capture site can include a chemical capture agent.

[0039] Support: A hydrogel support that can have a sequencing library contained therein, or a solid support that can have sequenceable nucleic acid fragments attached to its surface.

[0040] Chemical capture agent: a material, molecule, or moiety that can attach, retain, or bind to a target molecule (e.g., a complex or sample). One example of a chemical capture agent is a capture nucleic acid (e.g., a capture oligonucleotide) that is complementary to at least a portion of the target nucleic acid or is attached to the target molecule. Another example of a chemical capture agent is a linking molecule. In the case of a natural DNA or RNA sample, the linking molecule may include a nucleic acid binding moiety at one end, such as an intercalator, that binds via charge or hydrophobic interactions. In the case of a cell sample, the linking molecule may include a cell membrane binding moiety (e.g., an antigen for a surface protein) or a membrane-spanning moiety (e.g., a phospholipid at one end). Yet another example of a chemical capture agent is a member of a receptor-ligand binding pair (e.g., avidin, streptavidin, biotin, lectin, carbohydrate, nucleic acid binding protein, epitope, antibody, etc.) that can bind to the target molecule (or to a linking moiety bound to the target molecule). Further examples of chemical capture agents include chemical reagents that can form electrostatic interactions, hydrogen bonds, or covalent bonds (e.g., thiol-disulfide exchange, click chemistry, Diels-Alder, etc.) with target molecules.

[0041] Complex: A carrier, such as a hydrogel or solid support, and a sequenceable nucleic acid fragment attached to or contained within the carrier. The carrier can also include one member of a binding pair, the other member being part of the capture site.

[0042] External fixative: a gas, liquid, or viscous medium that is immiscible with the complexes or samples introduced into the flow cell lane(s) or chamber. A gaseous external fixative can be used to create droplets around the complexes or samples. An example of a gaseous external fixative is air that is guided through the flow cell at a suitable flow rate. For example, air can be used to aspirate a fluid containing the complexes or samples from the flow cell, which form droplets. The droplets that form act as a diffusion barrier. A liquid or viscous medium is used to prevent diffusion of the sequencing library that is released from the complexes or formed in the chamber on the flow cell surface. The external fixative can form a diffusion barrier because little or no solvation of the sequencing library or any other polynucleotides occurs in the external fixative. Examples of external fixatives in liquid form include hydrophobic oils such as mineral oil, silicone oil, perfluorinated oil, fluorocarbon oil (e.g., 3M's FLUORINERT™ Electronic Liquid FC40), or combinations thereof. Examples of external fixatives in the form of a viscous medium include buffers containing polymers (e.g., polyethylene glycol, polyvinylpyrrolidone, etc.), dextran, sucrose, glycerol, etc. In some examples, the viscous medium is a temperature-responsive gel. Temperature-responsive gels are non-viscous at the non-seeding temperature and turn into a viscous medium at the seeding temperature. Examples of temperature-responsive gels include poly(N-isopropylacrylamide) and polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) / Laponite nanoparticle composites.

[0043] Fragment: A portion or piece of genetic material (e.g. DNA, RNA, etc.).

[0044] Hydrogel or Hydrogel Matrix: A semi-rigid polymeric material that is permeable to liquids and gases. The polymeric materials that form hydrogels may be linear or lightly crosslinked via covalent, ionic, or hydrogen bonds. In one example, a hydrogel comprises about 60% to about 90% fluid, such as water, and about 10% to about 30% polymer. A hydrogel may be porous, i.e., contain open / void space. Porosity is the volume fraction (dimensionless) of the hydrogel, i.e., measures the void space in the material and is the ratio of void volume to total volume, as a percentage of 0 to 100% (or a ratio of 0 to 1). In one example, the porosity of a hydrogel may range from about 50% (0.5) to about 99% (0.99). The porosity may be sufficient to allow diffusion of reagents (e.g., enzymes, chemicals, and smaller sized oligonucleotides (less than 50 base pairs, e.g., primers) but prevent diffusion of larger sized nucleic acid molecules (e.g., samples, fragments, etc.).

[0045] The term "cationic polymer hydrogel" as used herein refers to an initial polymerized hydrogel having a cationic moiety i) incorporated into one of the monomer units or ii) attached to one of the monomer units via a linker. The term "initial polymer hydrogel" as used herein refers to a polymerized hydrogel prior to any reaction / interaction to introduce the cationic moiety. A cationic polymer hydrogel may also be referred to herein as a positively charged hydrogel.

[0046] Hydrogel support: a hydrogel having an at least substantially spherical shape (eg, hydrogel beads) within which a sequencing library can be contained.

[0047] Nucleic Acid Molecule: A polymeric form of nucleotides of any length and can contain ribonucleotides, deoxyribonucleotides, their analogs, or mixtures thereof. The term can refer to single- or double-stranded polynucleotides.

[0048] A "target" or "template" nucleic acid molecule can refer to the sequence to be analyzed.

[0049] Nucleotides in a nucleic acid molecule may include naturally occurring nucleic acids and their functional analogs. Examples of functional analogs may hybridize to a nucleic acid in a sequence-specific manner or may be used as a template for replicating a particular nucleotide sequence. Naturally occurring nucleotides generally have a backbone containing a phosphodiester bond. Analog structures may have alternative backbone linkages, including any of a variety known in the art. Naturally occurring nucleotides generally have a deoxyribose sugar (e.g., found in DNA) or a ribose sugar (e.g., found in RNA). Analog structures may have alternative sugar moieties, including any of a variety known in the art. Nucleotides may include natural or unnatural bases. Natural DNA may include one or more of adenine, thymine, cytosine, and / or guanine, and natural RNA may include one or more of adenine, uracil, cytosine, and / or guanine. Any unnatural base may be used, including locked nucleic acids (LNA) and bridged nucleic acids (BNA).

[0050] Positively charged moiety: A positively charged moiety can be any functional group that carries or can carry a positive charge. In one example, a positive charge can be introduced to the charged moiety by a substitution reaction. In another example, a positively charged moiety carries a positive charge at a particular pH (e.g., physiological pH).

[0051] Primer: A nucleic acid molecule that can hybridize to a target sequence of interest. In one example, a primer serves as a substrate onto which nucleotides can be polymerized by a polymerase. For example, an amplification or capture primer can serve as an initiation point for template amplification and cluster generation. In another example, a synthesized nucleic acid strand can contain a site to which a primer (e.g., a sequencing primer) can hybridize to initiate synthesis of a new strand that is complementary to the synthesized nucleic acid strand. Any primer can contain any combination of nucleotides or their analogs. In some examples, a primer is a single-stranded oligonucleotide or polynucleotide. The length of a primer can be any number of bases long and can contain a variety of non-natural nucleotides. In one example, a sequencing primer is a short strand ranging from 10 to 60 bases, or 20 to 40 bases.

[0052] Sample: Any source of genetic material, such as a cell, a microbiome, or a nucleic acid. In some examples, the cell is a single cell, including a prokaryotic or eukaryotic cell. In some examples, the cell is a mammalian cell, a human cell, or a bacterial cell. In some examples, the nucleic acid is a long DNA molecule, including viral nucleic acid, bacterial nucleic acid, or mammalian nucleic acid. In some examples, the sample is bound (as a fragment) via a transposon insert bound to the surface of a solid support (e.g., a bead).

[0053] Sequenceable nucleic acid fragment: a portion (fragment) of genetic material with adapters at the 3' and 5' ends. In a sequenceable nucleic acid fragment, each adapter contains a known universal sequence (e.g., complementary to at least a portion of a primer on a flow cell) and a sequencing primer sequence. Both adapters can also contain an index (barcode or tag) sequence. In one example, one side (e.g., P5 side) can contain a bead (or other solid support) index and the other side (e.g., P7 side) can contain a sample index. Sequenceable nucleic acid fragments can be attached to the surface of a solid support (e.g., beads) via transposon insertion or directly immobilized via a binding pair or other cleavable linker. Sequenceable nucleic acid fragments can also be contained within a hydrogel support.

[0054] Seeding: Immobilization of compatible fragments (e.g., sequenceable nucleic acid fragments) on the hydrogel of one example of a flow cell disclosed herein.

[0055] Sequencing library: A collection of nucleic acid fragments of one or less target nucleic acid molecules, or a collection of amplicons of the fragments. In some examples, the fragments are linked to one or more adapters at their 3' and 5' ends. In some examples, a sequencing library is prepared from one or more target nucleic acid molecules and is part of a complex.

[0056] Solid support: a body made of rigid or semi-rigid material, with a shape characterized as, for example, a sphere, an ovoid, a microsphere, or other recognized particle shape, whether or not it has regular or irregular dimensions. The solid support can have a sequencing library attached thereto. Examples of materials useful for the solid support include, but are not limited to, glass; plastic, such as acrylic, polystyrene, or copolymers of styrene with another material, polypropylene, polyethylene, polybutylene, polyurethane, or polytetrafluoroethylene (TEFLON® from The Chemours Co.); polysaccharides or cross-linked polysaccharides, such as agarose or sepharose; nylon; nitrocellulose; resin; silica or silica-based materials, including silicon and modified silicon; carbon fiber, metal; inorganic glass; optical fiber bundles, or various other polymers. Examples of solid supports include controlled pore glass beads, paramagnetic beads, thoria sol, Sepharose beads, nanocrystals and others known in the art, e.g., as described in the Microsphere Detection Guide from Bangs Laboratories (Fishers Ind.).

[0057] Tagmentation: modification of nucleic acid molecules (e.g., DNA or RNA samples) by transposomes to fragment the nucleic acid molecules and ligate adapters to the 5' and 3' ends of the fragments in a single step. Tagmentation reactions can be used to prepare sequencing libraries, particularly complexes that include solid supports. Tagmentation reactions combine random sample fragmentation and adapter ligation into a single step, thereby increasing the efficiency of the sequencing library preparation process.

[0058] Transposome: A nucleic acid that contains an integration enzyme (eg, an integrase or transposase) and an integration recognition site (eg, a transposase recognition site).

[0059] Universal nucleotide sequence: a region of sequence common to two or more nucleic acid molecules that also have regions that differ from each other. A universal sequence present in different members of a collection of molecules allows the capture of several different nucleic acids using a population of universal capture nucleic acids (i.e., adapters with sequences that are complementary to at least a portion of the primers). Similarly, a universal sequence present in different members of a collection of molecules allows the amplification or replication of several different nucleic acids using a population of universal sequencing binding sites (sequencing primer sequences).

[0060] Methods for producing a positively charged flow cell surface

[0061] An example method 100 for forming an example flow cell is shown in Figure 1. As shown, the example method 100 includes introducing a fluid including positively charged moieties into a flow cell including an initial polymer hydrogel having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups, and amplification primers attached to the initial polymer hydrogel (reference numeral 102), and incubating the initial polymer hydrogel in the fluid at a temperature for a period of time, thereby forming a cationic polymer hydrogel including cationic moieties (reference numeral 104).

[0062] The method 100 is also illustrated generally in Figures 2A and 2B.

[0063] As shown in FIG. 2A, at the start of the method 100, the flow cell 10 P (which is a precursor to the flow cell 10 shown in FIG. 2B) includes a substrate 12, an initial polymer hydrogel 14' on the substrate 12, and an amplification primer 18 attached to the initial polymer hydrogel 14'.

[0064] The substrate 12 is generally rigid and insoluble in aqueous liquids. Examples of suitable substrates 12 include epoxy siloxanes, polyhedral oligomeric silsequioxanes (POSS) or derivatives thereof, glass, modified glass, plastics, nylon, ceramic / ceramic oxides, silica (silicon oxide (SiO 2 )), fused silica, silica-based materials, aluminum silicate, silicon, modified silicon (e.g., boron-doped p+ silicon), silicon nitride (Si 3 N 4 ), tantalum pentoxide (TaO 5 ), or other tantalum oxide(s) (TaO x ), hafnium oxide (HfO 2 ), inorganic glass, and the like. Examples of POSS can be those described in Kehagias et al., Microelectronic Engineering 86 (2009), pp. 776-778, which is fully incorporated herein by reference. Some examples of plastics suitable for the substrate 12 include acrylic, polystyrene, copolymers of styrene with other materials, polypropylene, polyethylene, polybutylene, polyurethane, polytetrafluoroethylene (e.g., TEFLON® from The Chemours Co.), cyclo-olefin polymers (COP) (e.g., ZEONOR® from Zeon), polyimide, and the like. The substrate 12 can also be glass or silicon or POSS with a coating layer of tantalum oxide or another ceramic oxide on the surface. Another example of a suitable substrate 12 is a silicon-on-insulator substrate.

[0065] The form of the substrate 12 may be a wafer, a panel, a rectangular sheet, a die, or any other suitable configuration. In one example, the substrate 12 may be a circular wafer or panel having a diameter ranging from about 2 mm to about 300 mm. As a more specific example, the substrate 12 is a wafer having a diameter ranging from about 200 mm to about 300 mm. In another example, the substrate 12 may be a rectangular sheet or panel having a maximum dimension of up to about 10 feet (about 3 meters). As a specific example, the substrate 12 is a die having a width ranging from about 0.1 mm to about 10 mm. Although exemplary dimensions are shown, it should be understood that a substrate 12 having any suitable dimensions may be used.

[0066] The substrate 12 shown in FIG. 2A has lanes 20 defined therein. The lanes 20 may be defined in the substrate 12 using any suitable technique, depending in part on the material(s) of the substrate 12. In one example, the lanes 20 are etched into a glass substrate 12. In another example, the lanes 20 may be patterned into a resin substrate 12 using photolithography, nanoimprint lithography, or the like. In yet another example, a separation material (not shown) may be applied to the substrate 12 such that the separation material defines the walls of the lanes 20 and the substrate 12 defines the bottom of the lanes 20.

[0067] In one example, the lanes 20 have a rectilinear configuration. The length and width of the lanes 20 may be less than the length and width, respectively, of the substrate 12, such that a portion of the substrate surface 22 surrounding the lanes 20 is available for bonding to a lid (not shown). In some cases, the width of each lane 20 can be at least about 1 mm, at least about 2.5 mm, at least about 5 mm, at least about 7 mmμm, at least about 10 mm, or more. In some cases, the length of each lane 20 can be at least about at least about 10 mm, at least about 25 mm, at least about 50 mm, at least about 100 mm, or more. The width and / or length of each lane 20 can be greater than, less than, or between the values ​​specified above. In one example, the lanes 20 are square (e.g., 10 mm×10 mm).

[0068] The depth of each lane 20 can be a monolayer thick when microcontact, aerosol, or inkjet printing is used to deposit the separation material that defines the lane walls. In other examples, the depth of each lane 20 can be about 1 μm, about 10 μm, about 50 μm, or more. In one example, the depth can range from about 10 μm to about 30 μm. In addition to the positively charged polymer hydrogel that attracts the released library fragments, this depth can help prevent lateral diffusion of the released library fragments between adjacent lanes 20, for example, when multiple lanes 20 are used. In another example, the depth is about 5 μm or less. It should be understood that the depth of each lane 20 can be greater than, less than, or between the values ​​specified above.

[0069] Although a single lane 20 is shown in FIG. 2A, it should be understood that the substrate 12 may include multiple lanes (eg, 2, 3, 4, 8, etc.) that are fluidically separated from one another.

[0070] In the example shown in Figure 2A, lane 20 has an initial polymer hydrogel 14' therein. Prior to the incorporation or attachment of cationic moieties 16 (Figure 2B), the hydrogel can be referred to as initial polymer hydrogel 14' (see Figure 2A). After the incorporation or attachment of cationic moieties 16, the hydrogel can be referred to as cationic polymer hydrogel 14 (see Figure 2B).

[0071] The initial polymer hydrogel 14' may be a copolymer of at least two different monomer units. The initial polymer hydrogel 14' may be a copolymer of at least two different monomer units. n (M2) m where M1 is a first monomeric unit, M2 is a second monomeric unit, n is an integer ranging from 1 to 50,000, and m is an integer ranging from 1 to 100,000. In the cationic polymer hydrogel 14, M1 may be replaced with M1' (described with reference to FIG. 3) or M1'' (described with reference to FIG. 4), but M2, n, and m are the same as described for the initial polymer hydrogel 14'. Examples of each of the monomeric units M1, M2 will now be described in more detail.

[0072] One of the monomer units M1 includes a surface moiety selected from the group consisting of a negatively charged atom, an azide group, and an alkyne group. The negatively charged atom can be any group that is easily displaced, for example, a relatively weak nucleophile. Some specific examples of negatively charged atoms include halogens such as bromine and iodine.

[0073] Each of these surface moieties of monomer unit M1 can be replaced by or covalently attached to amplification primer 18. For example, the bromine can be replaced by a phospho-thioate group on the 5' end of primer 18. In another example, an azide group can be covalently linked to an alkyne group at the 5' end of primer 18. In yet another example, an alkyne group can be covalently attached to an azide group at the 5' end of primer 18.

[0074] Each of these surface moieties of the monomer unit M1 can also allow for the attachment of cationic moieties 16 to the initial polymer hydrogel 14' to produce the cationic polymer hydrogel 14.

[0075] In some examples, the surface moiety of monomer unit M1 is replaced by cationic moiety 16, thus incorporating cationic moiety 16 into monomer unit M1. In other words, cationic moiety 16 is attached to monomer unit M1 at the same position where the surface moiety was attached. For example, the surface moiety is a weaker redox species than cationic moiety 16, and a substitution reaction can occur in which the surface moiety is exchanged for cationic moiety 16. An example of a replaceable surface moiety is a negatively charged atom, such as bromine.

[0076] In another example, the surface moiety reacts with a linker to attach the cationic moiety 16 to the monomer unit M1. For example, an azide group can be covalently linked to a terminal alkyne group of the linker. As yet another example, an alkyne group can be covalently linked to a terminal add group of the linker.

[0077] It should be understood that due to the multifunctionality of the surface moieties of monomer unit M1, some of the surface moieties of monomer unit M1 are attached to amplification primer 18 and some of the surface moieties are replaced by or attached to cationic moieties 16. In some cases, the amount of amplification primer 18 attached ranges from about 10 times to about 50 times the amount of cationic moieties 16 attached.

[0078] Any monomeric unit M1 that includes a surface moiety as disclosed herein and that can be copolymerized with other monomeric unit(s) M2 can be used to form the initial polymer hydrogel 14'. In one example, the monomeric unit M1 (including the surface moiety) also includes an acrylamide unit: [ka] Variations of the acrylamide unit may also be used, for example, the carbon in the alkene may be optionally substituted or the N may be optionally substituted. Examples of other acrylamide units include methacrylamide, N,N-dimethylacrylamide, ethylacrylamide, and the like.

[0079] One specific example of a monomer unit M1 that contains both an acrylamide unit and a bromine as a negatively charged atom is N-(5-bromoacetamidylpentyl)acrylamide (brapa): [ka] Variations of N-(5-bromoacetamidylpentyl)acrylamide may also be used, for example those with the alkyl chain -(CH 2 )- may range from 1 to 50, and / or -(CH 2 Each of the )- can be optionally substituted.

[0080] One specific example of a monomer unit M1 that contains both an acrylamide unit and an azide group is N-(5-azidoacetamidylpentyl)acrylamide: [ka] Variations of N-(5-azidoacetamidylpentyl)acrylamide may also be used, for example those with the alkyl chain -(CH 2 )- may range from 1 to 50, and / or -(CH 2 Another example of a monomer unit M1 that includes both an acrylamide unit and an azide group is represented by: [ka] In the formula, R 1 is H or C1-C4 alkyl, R 2is H or C1-C4 alkyl; L is a linking group comprising a linear chain having 2-20 atoms selected from the group consisting of carbon, oxygen, and nitrogen, and optional substituents on the carbon atoms and any nitrogen atoms in the linear chain; E is a linear chain having 1-4 atoms selected from the group consisting of carbon, oxygen, and nitrogen, and optional substituents on the carbon atoms and any nitrogen atoms in the linear chain; A is an N-substituted amide having H or C1-C4 alkyl attached to the N; and Z is a nitrogen-containing heterocycle. Examples of Z include 5-10 ring members present as single ring structures or fused structures. Yet another example of a monomeric unit M1 comprising both an acrylamide unit and an azide group is represented by: [ka] In the formula, R 3a is selected from hydrogen, optionally substituted alkyl, optionally substituted phenyl, or optionally substituted C7-C14 aralkyl; R 3b is selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl; L 1 is selected from an optionally substituted alkylene linking group or an optionally substituted heteroalkylene linking group.

[0081] One specific example of a monomer unit M1 that contains both an acrylamide unit and an alkyne group is N-propargyl acrylamide: [ka]

[0082] It should be understood that other monomer units M1 may be used to form the initial polymer hydrogel 14', so long as the other monomer units M1 are functionalized with one of the surface moieties disclosed herein.

[0083] To form the initial polymer hydrogel 14', any of the monomer units M1 can be copolymerized with a second monomer unit M2. Examples of second monomer units M2 include acrylamide units, N,N-dimethylacrylamide units: [ka] In the formula, R 4a is selected from hydrogen, optionally substituted alkyl, optionally substituted phenyl, or optionally substituted C7-C14 aralkyl; R 4b is selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl; L 2 is selected from an optionally substituted alkylene linking group or an optionally substituted heteroalkylene linking group. The second monomer unit M2 does not include a surface moiety (e.g., a negatively charged atom, an azide group, or an alkyne group) of the first monomer unit M1.

[0084] In yet other examples, monomer unit M1 can be copolymerized with both an acrylamide unit (e.g., monomer unit M2) and an N,N-dimethylacrylamide unit (e.g., monomer unit M3) to form the initial polymer hydrogel 14'. In these examples, the initial polymer hydrogel 14' can be composed of (M1) n (M2) m (M3) q where n is an integer from 1 to 50,000, m is an integer ranging from 1 to 100,000, and q is an integer ranging from 1 to 100,000. In the corresponding cationic polymer hydrogel 14, M1 may be replaced with M1' (described with reference to FIG. 3) or M1'' (described with reference to FIG. 4), while M2, M3, n, m, and q are the same as described for the initial polymer hydrogel 14'.

[0085] In some embodiments, the initial polymer hydrogel 14' (M1) n (M2) m Or (M1) n (M2) m (M3)q (and the corresponding cationic polymer hydrogel 14) can be a linear copolymer or a lightly crosslinked copolymer. The molecular weight of the initial polymer hydrogel 14' can range from about 10 kDa to about 1500 kDa, or in certain examples, can be about 312 kDa or about 500 kDa. The molecular weight of the cationic polymer hydrogel 14 can be greater than the corresponding initial polymer hydrogel 14', depending on the cationic moieties 16 incorporated therein, or the cationic moieties 16 and linkers attached thereto.

[0086] Those skilled in the art will recognize that the sequences of repeating "n" and "m" or "n", "m", and "q" are representative and that the monomer subunits may be present in any order (e.g., random, block, patterned, or combinations thereof) in the initial polymer hydrogel 14' / cationic polymer hydrogel 14 structure.

[0087] To introduce the initial polymer hydrogel 14' into lane 20, copolymer ((M1) n (M2) m Or (M1) n (M2) m (M3) q A mixture of the copolymer (either ethanol or water) can be formed and then applied to the substrate 12. In one example, the copolymer can be present in a mixture (e.g., with water or ethanol and water). The copolymer mixture can then be applied to the substrate surface(s) 22 using spin coating, or immersion or dip coating, or flow of material under positive or negative pressure, or another suitable technique.

[0088] In some examples, substrate surface 22 (including the portion exposed to lane 20) may be activated and then the copolymer mixture may be applied thereto. In one example, a silane or silane derivative (e.g., norbornene silane) may be deposited on substrate surface 22 using vapor deposition, spin coating, or other deposition methods. In another example, substrate surface 22 may be exposed to plasma ashing to generate surface-activating agent(s) (e.g., -OH groups) that can attach to the copolymer. In yet another example, plasma ashing, followed by silanization, may be used to activate substrate surface 22.

[0089] Depending on the copolymer, the applied mixture can be subjected to a curing process to form an initial (covalently bonded) polymer hydrogel 14' across surface 22. In one example, curing can occur at a temperature ranging from room temperature (e.g., about 25° C.) to about 95° C. for a time ranging from about 1 millisecond to about several days. Abrasion can then be performed to remove the initial polymer hydrogel 14' from surface 22 around the substrate 12, while leaving the initial polymer hydrogel 14' at least substantially intact on surface 22 of lane 20.

[0090] Flow Cell 10 P also includes amplification primer 18.

[0091] A grafting process can be performed to graft the amplification primer 18 to the initial polymer hydrogel 14' in lane 20. In one example, the amplification primer 18 can be fixed to the initial polymer hydrogel 14' by a single point covalent attachment at or near the 5' end of the primer 18. This attachment i) frees the adaptor-specific portion of the primer 18 to anneal to its cognate sequenceable nucleic acid fragment and ii) frees the 3' hydroxyl group for primer extension. Any suitable covalent attachment can be used for this purpose. Examples of terminal primers that can be used include alkyne-terminated primers (e.g., which can be attached to an azide surface moiety of the initial polymer hydrogel 14'), phospho-thioate-terminated primers (e.g., which can be attached to a bromine surface moiety of the initial polymer hydrogel 14'), or azide-terminated primers (e.g., which can be attached to an alkyne surface moiety of the initial polymer hydrogel 14'). Specific examples of suitable primers 18 include the P5 and P7 primers used on the surface of commercially available flow cells sold by ILLUMIna INC. for sequencing on HiSeq™, HiSeqX™, MiSeq™, MiSeqDX™, MiNISeq™, NextSeq™, NextSeqDX™, NovaSeq™, Genome Analyzer™, ISEQ™, and other instrument platforms.

[0092] In one example, grafting may include flow-through deposition (e.g., using a temporarily or permanently attached lid), dunk coating, spray coating, puddle dispensing, or another suitable method of attaching the primer(s) 18 to the nascent polymer hydrogel 14' in lane 20. Each of these exemplary techniques may utilize a primer solution or mixture, which may include primer(s), water, a buffer, and a catalyst. By any of the grafting methods, the primer 18 reacts with reactive groups (e.g., surface moieties of monomer units M1) of the nascent polymer hydrogel 14' in lane 20 and has no affinity for the surrounding substrate 12. Thus, the primer 20 selectively grafts to the nascent polymer hydrogel 14' in lane 20.

[0093] The concentration of primer 18 in the primer solution or mixture may be such that some of the surface moieties of monomer units M1 of the initial polymer hydrogel 14' remain available for interaction or reaction to introduce cationic moieties 16 (Figure 2B).

[0094] As shown in FIG. 2A, a fluid 24 containing positively charged moieties 26 is introduced into the flow cell 10. P The initial polymer hydrogel 14' can be incubated in fluid 24 at a sufficient temperature and for a sufficient time to form a cationic polymer hydrogel 14 that includes cationic moieties 16 (shown in FIG. 2B).

[0095] The fluid 24 and positively charged moieties 26 used may depend on the initial polymer hydrogel 14', and in particular on the surface moieties of the monomer units M1 in the initial polymer hydrogel 14'. The incubation temperature and time may also depend on the positively charged moieties 26 and the initial polymer hydrogel 14'.

[0096] Some examples of positively charged moieties 26 incorporate themselves into monomer units M1 of the initial polymer hydrogel 14' to form cationic polymer hydrogel 14 including cationic moieties 16. When cationic moieties 16 are "incorporated into monomer units of the initial polymer hydrogel," it means that the cationic moieties 16 have replaced surface moieties of monomer units M1 of the initial polymer hydrogel 14'. In this example, the surface moieties are negatively charged atoms and the positively charged moieties 26 are stronger redox species than the negatively charged atoms. As an example, the negatively charged atoms of monomer units M1 are bromine and the positively charged moieties are selected from the group consisting of tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine, and tris(2-carboxyethyl)phosphine. Any of these phosphine positively charged moieties can substitute for a bromine atom in the monomer unit M1 of the initial polymer hydrogel 14', such that the corresponding phosphonium cation becomes part of the monomer unit M1' of the cationic polymer hydrogel 14 (see FIG. 3). Table 1 illustrates the positively charged moieties 26 used in the bromine substitution reaction and the corresponding cations that are incorporated into the monomer unit M1' of the cationic polymer hydrogel 14. In each of these examples, the counterion is bromide (Br-). [Table 1]

[0097] An example of a displacement reaction is shown in Figure 3. In this example, the initial polymer hydrogel 14' is a silane-free acrylamide that includes N-(5-bromoacetamidylpentyl)acrylamide as the first monomer unit M1 and acrylamide as the second monomer unit M2. When exposed to a fluid 24 that includes a positively charged moiety 26 (which in this example is tris(hydroxypropyl)phosphine), the positively charged moiety 26 replaces a negatively charged atom of the initial polymer hydrogel 14'. The displacement reaction results in a cationic polymer hydrogel 14 that includes a cationic moiety 16 (which in this example is a tris(hydroxypropyl)phosphonium cation) attached to the monomer unit M1', and a bromine attached to the monomer unit M1.

[0098] In the example shown in FIG. 3, fluid 24 may include a buffer solution having a pH in the range of 6 to 12. By way of example, the buffer solution may be a Tris buffer or an ethanolamine buffer. The concentration of positively charged moieties 26 in fluid 24 may range from about 1 mM to about 500 mM. In one example, the concentration of positively charged moieties 26 in fluid 24 may range from about 50 mM to about 400 mM. In another example, the concentration of any of the phosphine positively charged moieties 26 in fluid 24 may be about 100 mM.

[0099] In this example, the incubation temperature ranges from about 18° C. to about 65° C., and the incubation time ranges from about 1.5 minutes to about 5 minutes.

[0100] It should be understood that the exemplary reaction shown in FIG. 3 is one example of a substitution reaction, and that other monomer units M1 (e.g., including other replaceable surface moieties), M2 and / or other positively charged moieties 26 may be used.

[0101] Another example of a positively charged moiety 26 is attached to a monomer unit M1 of an initial polymer hydrogel 14' via a linker 28 (FIG. 4) to form a cationic polymer hydrogel 14 that includes a cationic moiety 16. By cationic moiety 16 "attached to a monomer unit of the polymer hydrogel via a linker" is meant that a surface portion of a monomer unit M1 of the initial polymer hydrogel 14' is reacted with the linker 28 to attach the cationic moiety 16.

[0102] In this example, the surface moiety is an azide or alkyne group, and the positively charged moiety 26 is covalently attached to the surface moiety via a linker 28. In one example, the surface moiety (of monomer unit M1) comprises a terminal azide group and the linker 28 comprises an alkyne group. In another example, the surface moiety (of monomer unit M1) comprises a terminal alkyne group and the linker 28 comprises an azide group.

[0103] In addition to the azide or alkyne group, linker 28 also contains a single -CH 2 -units, and may also include some -CH 2 -unit 、 Some CH 2 CH 2 The linker 28 may comprise an O-unit, an oligonucleotide chain, or another polymer chain. In one example, the linker 28 is a bifunctional DNA oligo. By "bifunctional" we mean that one end of the DNA oligo linker has one end group that can be attached to the initial polymer hydrogel 14' and another end group that can be attached to the cationic moiety 16.

[0104] Any of the examples of linker 28 may also be cleavable. By "cleavable" it is meant that linker 28 comprises a cleavable bond, such that cationic moiety 16 can be removed from the flow cell surface. As examples, linker 28 comprises a cleavable disulfide bond, a photocleavable bond, a cleavable phosphodiester bond, or a combination thereof. As an example, the phosphodiester bond of a DNA oligo may be cleaved via enzymatic cleavage. As another example, linker 28 may comprise a cleavable disulfide bond (SS) or a photocleavable bond, such as a photocleavable spacer: [ka] (available from Integrated DNA Technologies). In one example, the cleavable bond is disposed between the terminal azide or alkyne group and the positively charged moiety 26. A cleavable bond in the linker 28 may be desirable so that the cationic moiety 16 can be removed from the cationic polymer hydrogel 14, such as after the library fragments are plated, the DNA is extracted from the lysate, etc. Cleavage of the cationic moiety 16 removes the positive charge and the flow cell surface returns to its initial charged state (e.g., the charge prior to introduction of the cationic moiety 16).

[0105] In this example, positively charged moiety 26 can be any group that carries or is capable of carrying a positive charge and that can be attached to linker 28. By way of example, positively charged moiety 26 can be an amine group, such as polylysine, polyamidoamine, etc., that can carry a positive charge at physiological pH (protonated amine group: R-NH as cationic moiety 16). 3 + ) or a quaternary ammonium salt capable of carrying a positive charge at a maximum pH (providing a quaternary ammonium cation as the cationic moiety 16: [ka] ), or a sulfonium ion: [ka] In some embodiments, the initial polymer hydrogel 14' may include a combination of different positively charged moieties 26.

[0106] In some embodiments, the positively charged moiety 26 is attached to a linker 28, and the resulting compound 30 (FIG. 4) is coupled to a flow cell 10. P The compounds 30 are introduced into the fluid 24 to produce the cationic polymer hydrogel 14. These compounds 30 may be commercially available or may be synthesized. As an example of a suitable compound 30, an azide- or alkyl-containing linker 28 may be attached to any one of the R groups of the amine group, the quaternary ammonium group, or the sulfonium ion. One example of a compound 30 is the following propargylcholine bromide: [ka] It contains an alkyne linker 28 attached to an N,N,N-trimethylethanolammonium cation, which is a choline derivative of a quaternary ammonium cation. Another example of compound 30 is azidoethyl-SS-ethylamine: [ka] (which contains an azide-containing linker 28 attached to an amine group (capable of forming a protonated amine), or propargyl-SS-ethylamine: [ka] (which includes an alkyl-containing linker 28 attached to an amine group (capable of forming a protonated amine). These two particular linkers 28 include an azide group (N 3 ) or alkyne group (C≡C), as well as a cleavable disulfide bond (SS) in the alkyl chain.

[0107] An example of the use of a linker 28 to attach a positively charged moiety 26 to an initial polymer hydrogel 14' is shown in Figure 4. In this example, the initial polymer hydrogel 14' comprises N-(5-azidoacetamidylpentyl)acrylamide as a first monomer unit M1 and acrylamide as a second monomer unit M2. Upon exposure to a fluid 24 containing a positively charged moiety 26 (which in this example is propargylcholine bromide), the azide group of the first monomer unit M1 and the alkyne group of compound 30 undergo a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The result of the CuAAC reaction is a cationic polymer hydrogel 14 comprising a cationic moiety 16 (which in this example is an N,N,N-trimethylethanolammonium cation) attached to the triazole of the monomer unit M1'.

[0108] In the example shown in FIG. 4, the fluid 24 may include water. The concentration of the compound 30 in the fluid 24 may range from about 100 nM to about 100 μM. Because the ligation reaction is a CuAAC reaction, the fluid 24 may also include a catalyst and a ligand, or a catalyst, a ligand, and a reducing agent. These components may be present in the flow cell 10 as they are ionized. P For example, CuSO may be added to the fluid 24 so that it is introduced into the 4 Any copper catalyst that produces copper(II) ions, such as copper(II) ions, may be used. Any ligand, such as N,N,N',N'',N''-pentamethyldiethylenetriamine (PMDTA), may be used. Any reducing agent, such as sodium ascorbate, may be used. In one example, fluid 24 includes about 0.25 mol % to about 2 mol % of the copper catalyst and about 5 mol % to about 10 mol % of the reducing agent.

[0109] In this example, the incubation temperature ranges from about 18° C. to about 60° C., and the incubation time ranges from about 30 minutes to about 12 hours. In another example, the incubation temperature for the CuAAC reaction ranges from about 18° C. to about 22° C., and the incubation time ranges from about 60 minutes (1 hour) to about 6 hours, or from about 6 hours to about 12 hours.

[0110] It should be understood that the exemplary reaction shown in FIG. 4 is one example of an attachment reaction and that other monomer units M1, M2, other linkers 28, and / or other positively charged moieties 26 may be used.

[0111] In yet another example, a combination of the methods illustrated in Figures 3 and 4 can be used to produce a cationic polymer hydrogel 14 that includes cationic moieties 16. One example is shown in Figures 5A and 5B.

[0112] In this example, a linker 28' containing a terminal azide or alkyne at one end and a terminal negatively charged atom (e.g., bromine, iodine, or another weak nucleophile) at the other end is attached to the surface portion of the monomer unit M1 of the initial polymer hydrogel 14'. When the linker 28' contains a terminal azide, the surface portion of the monomer unit M1 is an alkyne, and when the linker 28' contains a terminal alkyne, the surface portion of the monomer unit M1 is an azide. The linking reaction can be carried out in a similar manner as described with reference to FIG. 4. This results in the modified polymer hydrogel 14'' as shown in FIG. 5A.

[0113] The modified polymer hydrogel 14" can then be subjected to a substitution reaction as described with reference to FIG. 3. A fluid 24 containing positively charged moieties 26 that are more positive than the negatively charged atoms (e.g., bromine) of the modified polymer hydrogel 14" is then passed through the flow cell 10. P As described with reference to FIG. 3, positively charged moieties 26 substitute and replace negatively charged atoms to form another example of a cationic polymer hydrogel 14.

[0114] When incubation is performed at a suitable temperature and for a suitable time, a cationic polymer hydrogel 14 is formed (as shown in FIG. 5B), which contains both cationic moieties 16 and amplification primer(s) 18 on its surface.

[0115] It should be understood that the exemplary reactions shown in Figures 5A and 5B are one example of a substitution and attachment reaction, and that other monomer units M1 (e.g., including other replaceable surface moieties), M2, other linkers 28, and / or other positively charged moieties 26 may be used.

[0116] A flow cell 10 having a positively charged (cationic) polymer hydrogel 14 is shown in Figure 2B. The flow cell 10 shown in Figure 2B includes a substrate 12, a cationic polymer hydrogel 14 on the substrate 12, cationic moieties 16 either i) incorporated into monomer units M1' of the cationic polymer hydrogel 14 or ii) attached to monomer units M1' of the polymer hydrogel 14 via linkers 28, 28', and an amplification primer 18 attached to the cationic polymer hydrogel 14.

[0117] The positively charged polymer hydrogel 14 can attract negatively charged complexes or samples introduced into the flow cell 10, thus eliminating the need for additional capture sites.

[0118] Additional Flow Cell Architectures

[0119] One example of a flow cell architecture is shown in FIG. 2B, although it should be understood that other flow cell architectures may be used.

[0120] Another example of a flow cell 10' is shown in Figure 6. This example is similar to the example shown in Figure 2B, except that the substrate 12 includes a plurality of recesses 32 separated by intervening regions 34, a cationic polymer hydrogel 14 (containing cationic moieties 16), and an amplification primer(s) 18 is disposed within each recess 32. In the example shown in Figure 6, the recesses 32 are defined in lanes 20.

[0121] In this example, recesses 32 may be patterned into the substrate 12. Patterning may include etching the recesses 32 into the substrate 12 and / or using imprint lithography. The recesses 32 may then be functionalized with cationic polymer hydrogel 14 (including cationic moieties 16) and amplification primer(s) 18 as described herein. The interstitial regions 34 between the recesses 32 do not have cationic polymer hydrogel 14 (including cationic moieties 16) or amplification primer(s) 18 thereon. This may be because the initial polymer hydrogel 14' has been polished away from the interstitial regions 34. After functionalization of the recesses 32, additional material 36 (e.g., a hydrophobic material) may be attached (bonded, adhered, etc.) to the substrate 12 (e.g., at the periphery) to define the walls of the lane 20 around the recesses 32.

[0122] The recesses 32 can be distributed across the flow cell 10' in any suitable pattern or layout. When the flow cell 10' includes multiple lanes 20, the pattern of recesses 32 can be the same, or different patterns of recesses 32 can be used in different lanes 20. Many different patterns / layouts of the recesses 32 can be envisioned, including regular, repeating, and non-regular patterns. In one example, the recesses 32 are arranged in a hexagonal grid for close packing and improved density. Other layouts can include, for example, parallelogram layouts (i.e., rectangular, square, etc.), triangular layouts, circular layouts, etc.

[0123] Each recess 32 may have any suitable shape (and corresponding three-dimensional shape), such as a circle (as shown in FIG. 6), an oval, a polygon (eg, a triangle, a quadrilateral, a pentagon, etc.), etc.

[0124] The size of each recess 32 may be characterized by its open area, diameter, and / or length and width.

[0125] The area occupied by each recess opening can be selected to prevent the complex from entering recess 32. In one example, the area of ​​each recess opening is at least about 1×10 -4 μm 2 , at least 1 × 10 -3 μm 2 , at least about 1 x 10 -2 μm 2 , at least about 0.1 μm 2 , at least about 0.5 μm 2 , at least about 1 μm 2 , or at least about 4 μm 2 The area occupied by each recess opening can be less than or between the values ​​specified above.

[0126] In some cases, the diameter or length and width of each recess 32 can be at least about 1 nm, at least about 50 nm, at least about 100 nm, at least about 500 nm, or more, but the dimensions are smaller than the diameter or length and width of the lane. Example recess diameters range from about 1 nm to about 500 nm. Another example recess diameter ranges from about 300 nm to about 2 μm.

[0127] The recesses 32 can also have a depth. By way of example, the depth of each recess 32 can be at least about 10 nm, at least about 50 nm, at least about 1 μm, and up to about 2 μm. It should be understood that the depth of each recess 32 can be greater than, less than, or between the values ​​specified above.

[0128] In one example, the aspect ratio (diameter:depth) of the recesses 32 can be in the range of about 1:1 to about 1:2, or about 1:1.25 to about 1:1.75.

[0129] In this example, adjacent recesses 32 may be separated by intervening regions 34 within a given lane 20. The average recess pitch represents the distance from the center of one recess 32 to the center of an adjacent recess 32 (center-to-center spacing) or from the right edge of one recess 32 to the left edge of an adjacent recess 32 (end-to-end spacing). The layout or pattern of recesses 32 may be regular such that the coefficient of variation of the average pitch is approximately small, or the layout or pattern may be irregular, in which case the coefficient of variation may be relatively large. In either case, the average pitch may be, for example, at least about 10 nm, at least about 0.1 μm, at least about 0.5 μm, or more, depending, for example, on the dimensions of the lane 20. Alternatively or additionally, the average pitch may be, for example, at most about 0.5 μm, at most about 0.1 μm, or less. The average pitch of a particular pattern of recesses 32 may be between one of the lower values ​​and one of the upper values ​​selected from the range above.

[0130] Another example of a flow cell 10'' is shown in FIG. 7. This example is similar to the example shown in FIG. 6, except that the substrate 12 further includes a plurality of chambers 38, 38', and a subset of the plurality of recesses 32 is located within the perimeter of each of the plurality of chambers 38, 38'. As in FIG. 6, a cationic polymer hydrogel 14 (including cationic moieties 16) and amplification primer(s) 18 are disposed within each of the recesses 32.

[0131] In this example, recesses 32 may be patterned into the substrate 12. Patterning may include etching the recesses 32 into the substrate 12 and / or using imprint lithography. The recesses 32 may then be functionalized with a cationic polymer hydrogel 14 (including cationic moieties 16) and amplification primer(s) 18 as described herein. Intervening regions 34 between the recesses 32 do not have a cationic polymer hydrogel 14 (including cationic moieties 16) or amplification primer(s) 18 thereon. After functionalization of the recesses 32, an additional material 36 (e.g., a hydrophobic material) may be attached (bonded, adhered, etc.) to the substrate 12 (e.g., at the periphery) to define walls of chambers 38, 38' around a subset of the recesses 32.

[0132] The chambers 38, 38' can be distributed across the substrate 12 in any suitable pattern or layout. Many different patterns / layouts of the chambers 38, 38' can be envisioned, including regular, repeating, and irregular patterns. In one example, the chambers 38, 38' are arranged in a hexagonal grid for close packing and improved density. Other layouts can include, for example, parallelogram layouts (i.e., rectangular, square, etc.), triangular layouts, circular layouts, etc. In some examples, the layout or pattern can be an xy format of the chambers 38, 38' in rows and columns.

[0133] The chambers 38, 38' may have any suitable shape, such as square, circular, oval, polygonal (eg, triangular, rectangular, pentagonal, etc.).

[0134] The size of each chamber 38, 38' may be characterized by its opening area, diameter, and / or length and width. As shown in FIG. 7, the flow cell 10'' has a plurality of recesses 32 located within each of the chambers 38, 38'. Thus, the size of the chambers 38, 38' is greater than the size of each of the recesses 32. In other words, the dimension(s) of the chambers 38, 38' are greater than the dimension(s) of each of the recesses 32. In this example, "dimension" refers to the area occupied by each chamber opening or recess opening, and / or the diameter of the chamber 38, 38' or recess 32, and / or the length and width of each chamber 38, 38' or recess 32. In the example shown in FIG. 7, the opening area and diameter of each of the chambers 38, 38' are greater than the opening area and diameter of each of the recesses 32. The opening area and diameter or length and width of each of the chambers 38, 38' depend on the number of recesses 32 to be located within the chambers 38, 38'.

[0135] The area occupied by each chamber opening can be selected to allow the composite (examples of which are shown in Figures 8A-8C) to enter chamber 38, 38'. In one example, the area of ​​each chamber opening is at least about 1 μm 2 , at least about 10 μm 2 , at least about 100 μm 2 The area occupied by each chamber opening can be any value greater than or between the values ​​specified above.

[0136] In some cases, the diameter or length and width of each chamber 38, 38' can be at least about 1 μm, at least about 10 μm, at least about 20 μm, at least about 30 μm, at least about 40 μm, at least about 50 μm, at least about 100 μm, or more. Example chamber diameters range from about 1 μm to about 1000 μm. Another example chamber diameter ranges from about 10 μm to about 50 μm. It should be understood that when the chambers 38, 38' have a length and a width, the length and width may be the same or different.

[0137] The chambers 38, 38' may also have a depth that depends on the technique used to form the chambers 38, 38'. For example, the depth of each chamber 38, 38' may be a monolayer thick when microcontact, aerosol, or inkjet printing is used to deposit the additional material 36 that defines the chambers 38, 38'. In other examples, the depth of each chamber 38, 38' may be about 1 μm, about 10 μm, about 50 μm, or more. In another example, the depth is at least about 50% of the average diameter of the complexes introduced into the chambers 38, 38'. In one example, the depth may range from about 10 μm to about 30 μm. In addition to the positively charged polymer hydrogel 14 attracting the released library fragments, the depth of the chambers 38, 38' may help prevent lateral diffusion of the released library fragments between adjacent chambers 38, 38'. Thus, the released library fragments may be retained within the chambers 38, 38' without any external immobilization agent. In another example, the depth is about 5 μm or less. It should be understood that the depth of each chamber 38, 38′ can be greater than, less than, or between the values ​​specified above.

[0138] Adjacent chambers 38, 38' may be separated by a surface of the additional material 36. The average chamber pitch represents the distance from the center of one chamber 38, 38' to the center of the adjacent chamber 38, 38' (center-to-center distance) or from the right edge of one chamber 38, 38' to the left edge of the adjacent chamber 38, 38' (end-to-end distance). The layout or pattern of the chambers 38, 38' may be regular such that the coefficient of variation of the average pitch is approximately small, or the layout or pattern may be irregular, in which case the coefficient of variation may be relatively large. In either case, the average pitch may be, for example, at least about 1 μm, at least about 5 μm, at least about 10 μm, at least about 100 μm, or more. In one example, the average pitch is twice the diameter of the chambers 14. The average pitch of a particular pattern of chambers 38, 38' may be between one of the lower values ​​and one of the upper values ​​selected from the range above. Although exemplary average chamber pitch values ​​have been provided, it should be understood that other average chamber pitch values ​​may be used.

[0139] Each subset of recesses 32 is located within the periphery of each of a plurality of chambers 38, 38'.

[0140] Although not shown in Figures 6 or 7, each lane 20 of flow cell 10' or each chamber 38, 38' of flow cell 10" can include a capture site capable of attracting a complex or sample introduced to the flow cell 10' or 10". More specifically, at least a portion of the intervening region 34 within a lane 20 or chamber 38, 38' can include a capture site.

[0141] The capture site(s) can physically and / or chemically immobilize a complex or sample on substrate 12 (eg, intervening region 34) in lane 20 or chamber 38, 38'.

[0142] The capture site(s) may be located in any suitable location. The location of the capture site(s) across substrate 12 may be uniform or non-uniform. The capture sites may have any suitable shape, geometry, and dimensions, which may depend at least in part on the configuration of the capture site (e.g., patch, well, protrusion, etc.) and the type of complex or sample to be captured by the capture site(s).

[0143] In some examples, the capture site(s) is a chemical capture agent that is applied to a portion of interstitial region 34. Any example of a chemical capture agent disclosed herein can be used. In one example, each chemical capture agent can be deposited at a desired location using microcontact printing, or another suitable technique.

[0144] In other examples, the capture site(s) comprise wells defined in the surface of the substrate 12. The wells may be formed using etching or imprinting depending on the substrate 12 used. The wells may have any suitable shape and geometry, such as those described herein for the recesses 32. In some examples, the wells do not have additional chemical capture agents added thereto. In these examples, the opening dimensions allow the complexes or samples to self-assemble (e.g., based on the shape) into the corresponding wells. In other examples, the wells have chemical capture agents added thereto.

[0145] Other examples of capture sites include wells and capture beads with chemical capture agents on their surfaces. The capture beads can be sized to fit into the wells. In some examples, the capture beads may be flush with or extend slightly above the adjacent intervening regions 34, so that the complexes or samples that eventually attach to them are not trapped within the well. In one example, the capture beads are selected from the group consisting of silicon dioxide, superparamagnetic materials, polystyrene, and acrylates. Any of the examples of chemical capture agents disclosed herein may be used on the surface of the capture beads or may be coated onto the capture beads prior to introduction into the wells.

[0146] The depth of the capture site can vary depending on whether a chemical capture agent is to be introduced thereto and whether a capture bead is to be introduced thereto. The depth can be selected to accommodate at least these materials (i.e., the material is contained within the well). In one example, the depth of the well ranges from about 1 nm to about 5 microns.

[0147] As another example, the capture site comprises a protrusion defined in the substrate 12. A protrusion is a three-dimensional structure that extends outward (upward) from an adjacent surface. The protrusion may be generated by etching, photolithography, imprinting, etc. Although any suitable three-dimensional geometry may be used for the protrusion capture site, a geometry having at least a substantially flat upper surface may be desirable. Examples of protrusion geometries include spheres, cylinders, cubes, polygonal prisms (e.g., rectangular prisms, hexagonal prisms, etc.), etc.

[0148] A different chemical capture agent can be applied to the top surface of each protrusion capture site. Any of the examples of chemical capture agents disclosed herein can be used, and any deposition technique can be used to apply the chemical capture agent to the top surface of the protrusion.

[0149] It should be understood that any combination of capture site types may be used together on the flow cell 10', 10'' (eg, capture agents and wells).

[0150] The flow cells 10, 10', 10'' are also shown without a lid attached to the substrate 12. It should be understood that some examples of the flow cells 10, 10', 10'' may have a lid attached to at least a portion of the substrate 12, such as at the surface 22. The lid may be disposed on the surface 22 so as to define a single flow path 20 or multiple fluidically separated flow lanes 20, or multiple chambers 38, 38', which may or may not be fluidically separated.

[0151] The lid can be any material that is transparent to the excitation light directed toward the substrate 12. By way of example, the lid can be glass (e.g., borosilicate, fused silica, etc.), plastic, etc. A commercially available example of a suitable borosilicate glass is D 263® available from Schott North America, Inc. Commercially available examples of suitable plastic materials, i.e., cycloolefin polymers, are the ZEONOR® products available from Zeon Chemicals LP.

[0152] The lid may be bonded to the substrate surface 22 using any suitable technique, such as laser bonding, diffusion bonding, anodic bonding, eutectic bonding, plasma activated bonding, glass frit bonding, or other methods known in the art. In one example, a spacer layer may be used to bond the lid to the substrate surface 22. The spacer layer may be any material that seals at least a portion of the substrate 12 and the lid together.

[0153] In other examples, the flow cell 10, 10', 10'' does not include a lid, but rather includes two substrates 12 bonded together. In these examples, the reactive surfaces of the substrates 12 (e.g., polymer hydrogel 14, primer 18) face each other. The substrates 12 can be bonded together using similar techniques and materials described for the lid and substrate 12.

[0154] kit

[0155] Flow Cell 10 P can be part of a kit that can be used to introduce positive charges into the initial polymer hydrogel 14'. In one example, the kit includes: i) a flow cell 10 including a substrate 12, an initial polymer hydrogel 14' disposed on the substrate 12 and having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups, and an amplification primer 18 attached to the initial polymer hydrogel 14'. P and ii) a fluid 24 that includes positively charged moieties 26 that interact or react with the surface moieties to form a cationic polymer hydrogel 14 that includes cationic moieties 16.

[0156] Any of the examples of flow cell architectures disclosed herein, including architectures for flow cells 10, 10', 10'', may be used with the flow cell 10 of the kit. P Further, any of the examples of substrates 12, initial polymer hydrogels 14', and amplification primers 18 can be used. Still further, any of the examples of fluids 24 that include positively charged moieties 26 can be used in the kits.

[0157] The kit may be used to perform the method 100 described herein.

[0158] Conjugates for use in flow cells

[0159] The example flow cells 10, 10', 10'' may be particularly suitable for use with the example complexes disclosed herein. The complexes include a carrier (e.g., a hydrogel support or a solid support) and a sequenceable nucleic acid fragment attached to or contained within the carrier. Examples of suitable complexes are shown in Figures 8A-8C. Although several exemplary methods for making the complexes are described, it should be understood that other methods may be used so long as the sequenceable nucleic acid fragment is attached to or contained within the carrier.

[0160] FIG. 8A illustrates a complex 40A that includes a solid support 42 and a sequenceable nucleic acid fragment 44 attached to the solid support 42.

[0161] In one example, to form the complex 40A, the adapter sequence 52, 52' is attached to the solid support 42 via one member 46 of a binding pair. In one example, the adapter sequence 52, 52' includes a first sequencing primer sequence (e.g., a lead 1 sequencing primer sequence) and a first sequence (e.g., a uracil modified P5 sequence) that is complementary to at least a portion of one of the amplification primers 18 (e.g., P5) on the flow cell 10, 10', 10''. The adapter sequence 52, 52' binds to one member 46 of the binding pair (e.g., biotin) and can thereby bind to a surface of the solid support 42 that includes the other member of the binding pair (e.g., avidin, streptavidin, etc.). The adapter sequence may also include an index sequence.

[0162] The Y adapter can be mixed with a transposase enzyme (e.g., two Tn5 molecules) to form a transposome. The Y adapter can include two mosaic end sequences that are hybridized to each other. One of the mosaic end sequences can be attached to another adapter 48, 48', which includes a second sequencing primer sequence (e.g., a lead 2 sequencing primer sequence) and a second sequence (e.g., a uracil-modified P7 sequence) that is complementary to at least a portion of another one of the amplification primers 18 (e.g., P7) on the flow cell 10, 10', 10'' and, optionally, an index / barcode sequence.

[0163] The tagmentation process can then be performed. A fluid (e.g., tagmentation buffer) containing a sample (e.g., DNA) can be added to the transposome and to the solid support 42 to which the adapter sequences 52, 52' are attached. When the sample contacts the transposome, the DNA is tagged (fragmented and tagged with the adapters 52, 52' on the solid support 42) and attached to the Y adapter (e.g., by ligation of the free mosaic end sequence). Successive tagmentations of the sample result in multiple bridge molecules between the transposomes. The bridge molecules wrap around the solid support 42. The transposome maintains the connectivity of the bridge molecules. To complete the sequenceable fragment 44, further extensions and ligations are performed to ensure that the sample fragments 50, 50' are attached to the sequences 48 and 48'.

[0164] The transposase enzyme can then be removed by sodium dodecyl sulfate (SDS) treatment or by heat or proteinase K digestion. Removal of the transposase enzyme leaves sequenceable nucleic acid fragments 44 attached to the solid support 42.

[0165] The resulting complex 40A is shown in FIG. 8A. The bridge molecules are sequenceable nucleic acid fragments 42, each of which includes a fragment 50, 50' and an adapter sequence 48 and 52 or 48' and 50' attached to either end. The adapter sequence 52, 52' is the sequence that is first bound to the solid support 42 and includes a first sequence of a sequencing primer and a first sequence that is complementary to a flow cell primer. The adapter sequence 52, 52' is attached to one member 46 of the bound complex / pair. The adapter sequence 48, 48' is from a Y adapter and includes a second sequence that is complementary to another flow cell primer and a second sequencing primer sequence. No PCR amplification is performed because each sequenceable nucleic acid fragment 44 includes a suitable adapter for amplification (e.g., bridge amplification) and sequencing. Thus, these fragments 44 are sequenceable. Furthermore, because the library fragments 44 are from the same sample, the fragments 44 may be suitable for linked long read applications.

[0166] FIG. 8B illustrates another complex 40B that includes a solid support 42 and a sequenceable nucleic acid fragment 44' attached to the solid support 42. In one example, a PCR-free nucleotide library is created in a tube, and then the library is hybridized to the solid support 42 in the tube. In the example shown in FIG. 8B, a primer having one member 46 of a binding pair (e.g., adapters 52'', 48'') is added to the library fragment 50'' in the tube, and then the sequenceable nucleic acid fragment 44' is attached to the solid support 42. In another example, the solid support 42 can have primers attached via a binding pair (e.g., avidin on the support 42 and biotin attached to the primer). These primers hybridize to adapters 52'' attached to the library fragment 50'' (so the primer and binding pair member are on one end of the fragment and not the other). In another example, extension can be performed using a strand-displacing enzyme. This results in a fully double-stranded library (e.g., no forks or Y-adapters as shown in Figure 8B). The sequenceable nucleic acid fragments 44' can be released on a flow cell via denaturation.

[0167] FIG. 8C shows an example of a complex 40C that includes a hydrogel support 54 and a sequenceable nucleic acid fragment 44'' contained within the hydrogel support 54.

[0168] To form this composite 40C, a fluid containing the hydrogel monomer(s) and / or polymer(s) and crosslinker(s) is mixed in the presence of the sample (e.g., genetic material). The fluid can be filled and emulsified in mineral oil or another suitable hydrophobic fluid to generate droplets. A radical initiator can be added to polymerize and / or crosslink the hydrogel monomer(s) and / or polymer(s) to form the hydrogel support 54.

[0169] When forming the composite 40C, the fluid may be water, the monomer may be selected from the group consisting of acrylamide, N,N'-bis(acryloyl)cystamine, bisacrylamide, diacrylate, diallylamine, triallylamine, divinylsulfone, ethylene glycol diallyl ether, ethylene glycol diacrylate, trimethylolpropane trimethacrylate, ethoxylated trimethylol diacrylate, ethoxylated pentaerythritol tetraacrylate, collagen monomer, and combinations thereof, and / or the polymer may be selected from the group consisting of polyethylene glycol-thiol, polyethylene glycol-acrylate, polyethylene glycol diacrylate, polyethylene glycol tetra ... The crosslinking agent may be selected from the group consisting of polyethylene glycol (e.g., having a weight average molecular weight ranging from about 100 to about 200,000), polypropylene oxide, polyacrylic acid, poly(hydroxyethyl methacrylate), poly(methyl methacrylate), poly(N-isopropylacrylamide), poly(lactic acid), poly(lactic-co-glycolic acid), polycaprolactone, poly(vinyl sulfonic acid), poly(L-aspartic acid), poly(L-glutamic acid), polylysine, agar, agarose, alginate, heparin, alginate sulfate, dextran sulfate, hyaluronan, pectin, carrageenan, gelatin, chitosan, cellulose, collagen polymers, and combinations thereof. The crosslinking agent forms bonds, e.g., disulfide bonds, in the polymer of the hydrogel support 54. The crosslinking agent may be reversible in that it can be crosslinked and uncrosslinked depending on the chemical to which it is exposed. For example, a reversible crosslinker is a bisacrylamide crosslinker that contains disulfide bonds that can be broken down with a reducing agent such as dithiothreitol (DTT), tris-(2-carboxyethyl)phosphine (TCEP), or tris-(3-hydroxypropyl)phosphine (THP).In one example, the crosslinking agent is selected from the group consisting of acrylamide, N,N'-bis(acryloyl)systeme, bisacrylamide, 1,4-diacroylpiperazine, N-N'-diallyl-L-tartardiamide, and N-N'-(1,2-dihydroxyethylene)-bis-acrylamide. In one example, the radical initiator may be a photoinitiator. Examples of photoinitiators include azobisisobutyronitrile, benzoyl peroxide, and eosin-5-isothiocyanate. This type of radical initiator may be used because it does not initiate crosslinking until exposed to light of the appropriate wavelength. In another example, the radical initiator may initiate crosslinking when exposed to a radical source. An example of this type of radical initiator is tetramethylethylenediamine (TEMED).

[0170] The sample is trapped within the hydrogel support 54 because it is too large to pass through the pores of the hydrogel support 54. In some examples, the sample is DNA or RNA and is at least about 100 nucleotides in length (e.g., 1,000 nucleotides or more, 10,000 nucleotides or more, 500,000 nucleotides or more, etc.). In some examples, the term "pore size" of the hydrogel support 54 refers to the average diameter or average effective diameter of the cross-sections of the pores based on measurements of multiple pores. The effective diameter of a non-circular cross-section is equal to the diameter of a circular cross-section having the same cross-sectional area as the non-circular cross-section. In one example, the pore size ranges from about 10 nm to about 100 nm.

[0171] Library preparation can then take place within the hydrogel support 54. Multiple reagent exchanges can take place through the pores of the hydrogel support 54. The sample and any library fragments generated therefrom are maintained within the hydrogel matrix. Library preparation can include fragmenting the sample and adding adaptors that result in sequenceable fragments 44''.

[0172] In one example, library preparation can be performed via tagmentation performed within the hydrogel support 54. The resulting complex 40C is shown in FIG. 8C. The adapter sequence includes suitable adapters for amplification and sequencing, so the resulting fragments 44'' are sequenceable. In another example, library preparation can be performed using polymerase extension, which results in a double-stranded library. This exemplary library needs to be denatured prior to release from the hydrogel support 54 and seeding.

[0173] Methods involving the complex

[0174] Some examples of the methods disclosed herein utilize a flow cell 10, 10', 10'' as well as any one of complexes 40A, 40B, or 40C as disclosed herein. As noted above, each of complexes 40A, 40B, or 40C contains sequenceable fragments obtained from the same sample of genetic material. When one or some of the complexes are isolated within a lane 20 or chamber 38, 38', spatial co-localization of libraries from the same sample is achieved.

[0175] In an exemplary method, complexes 40A, 40B, or 40C are introduced into flow cell 10, 10', 10'', for example, through one or more input ports. Complexes 40A, 40B, or 40C may be introduced into a fluid, such as Tris-HCl buffer or 0.5x saline sodium citrate (SSC) buffer. At least some of complexes 40A, 40B, or 40C from the fluid settle into at least some of lane(s) 20 and / or chambers 38, 38'. When flow cell 10 is in use, negatively charged sequenceable fragments 44, 44', 44' of complexes 40A, 40B, or 40C may be attracted to positively charged polymer hydrogel 14 in lane 20. When flow cell 10' or 10'' is in use, positively charged polymer hydrogel 14 is trapped within recess 32. In some of these examples, complex 40A, 40B, or 40C may partially settle and remain in lane 20 or chamber 38, 38' due to the depth of lane 20 or chamber 38, 38'. In some other of these examples, lane 20 or chamber 38, 38' may include a capture site to which complex 40A, 40B, or 40C adheres.

[0176] It should be understood that some complexes 40A, 40B, or 40C may not precipitate, and these complexes 40A, 40B, or 40C are removed from the flow cell 10, 10', 10'' prior to further processing. It should also be understood that some lanes 20 or chambers 38, 38' may receive one or more of complexes 40A, 40B, or 40C, while others of the lanes 20 or chambers 38, 38' may not receive complexes 40A, 40B, or 40C. The distribution of complexes 40A, 40B, or 40C may be random when no capture sites are included, or may be more controlled when capture sites are included.

[0177] The exemplary method then includes washing the untrapped complexes 40A, 40B, or 40C from the flow cell 10, 10', 10". Washing may include introducing a fluid into the flow cell 10, 10', 10". The flow may sweep any unsettled complexes 40A, 40B, or 40C out an outlet of the flow cell 10, 10', 10".

[0178] This example of the method then includes causing the carrier of the trapped complex 40A, 40B, or 40C (e.g., solid support 42 or hydrogel support 54) to release the sequenceable nucleic acid fragment 44, 44', or 44'' into lane 20 or chamber 38, 38', respectively, in which each complex 40A, 40B, or 40C is trapped.

[0179] The release of the sequenceable nucleic acid fragments 44, 44', or 44'' on the carrier (i.e., support 42 or 54) can vary depending on the complex 40A, 40B, or 40C used. In one example, the carrier is a solid support 42, and its triggering requires the introduction of a cleavage agent to the flow cell 10, 10', 10''. The cleavage agent can initiate chemical, enzymatic, or photochemical release of the sequenceable nucleic acid fragments 44, 44' from the solid support 42. In these examples, another stimulus such as heat or light can actuate the cleavage agent to release the library fragments 44 or 44' from the solid support 42. As an example, free biotin can be introduced as a cleavage agent and heated to about 92° C. to induce biotin-oligo release from the solid support 42.

[0180] In other examples, complex 40C is used and thus the carrier is a hydrogel support 54. In these other examples, inducing library release may require heating the flow cell 10, 10', 10" to introduce a cleavage agent into the flow cell 10, 10', 10", or combinations thereof. Heating to release the library fragments 44" from the hydrogel support 54 may require heating to a temperature of about 90°C. The entire flow cell 10, 10', 10" may be heated and as the complex 40C heats up, the hydrogel support 54 may degrade to release the fragments 44". In some examples, the cleavage agent may include one or more components that may depolymerize the hydrogel support 54 and release the sequenceable fragments 44" therefrom. By way of example, the cleavage agent may include dithiothreitol (DTT), tris-(2-carboxyethyl)phosphine (TCEP), or tris-(3-hydroxypropyl)phosphine (THP). In other examples, the cleavage agent is light. In these examples, the crosslinker used to form the hydrogel support 54 can include a photocleavable moiety, such that exposure of complex 40C to light of an appropriate wavelength can cleave the moiety and degrade the hydrogel support 54.

[0181] The transport and seeding of the sequenceable nucleic acid fragments 44, 44', or 44'' is controlled in part by the positive charge of the cationic polymer hydrogel 14. The sequenceable nucleic acid fragments 44, 44', 44'' are negatively charged and are therefore attracted to the positively charged polymer hydrogel 14. Thus, the fragments 44, 44', or 44'' of any particular complex 40A, 40B, or 40C are trapped in the lane 20 or chamber 38, 38' in which the particular complex 40A, 40B, or 40C is trapped.

[0182] In addition to the attractive force of the cationic polymer hydrogel 14, the depth of the lane 20 or chamber 38, 38' may also limit the transport and seeding of the sequenceable nucleic acid fragments 44, 44', or 44'', so an external immobilization agent may not be introduced into the flow cell 10, 10', 10''.

[0183] The flow cell 10, 10', 10" disclosed herein allows the cationic polymer hydrogel 14 to attract the sequenceable nucleic acid fragments 44, 44', or 44" immediately upon their release, thereby allowing the amplification primers 18 to seed the released sequenceable nucleic acid fragments 44, 44', or 44" in a relatively confined manner. In one example, seeding is accomplished by hybridization between a first or second sequence of the fragments 44, 44', or 44" and a complementary sequence of the primers 18. Seeding may be performed at a suitable hybridization temperature for the fragments 44, 44', or 44" and the primer(s) 18.

[0184] The seeded sequencing library can then be amplified using any suitable method, such as cluster generation.

[0185] In one example of cluster generation, a sequenceable nucleic acid fragment 44, 44', or 44'' is copied from the hybridized primer 18 by 3' extension using a high-fidelity DNA polymerase. The original sequenceable nucleic acid fragment 44, 44', or 44'' is denatured, leaving an immobilized copy in the lane 20 or recess 32. Isothermal bridge amplification can be used to amplify the immobilized copy. For example, the copied template loops over and hybridizes to an adjacent complementary primer 18, and the polymerase copies the copied template to form a double-stranded bridge, which is denatured to form two single strands. These two strands loop over and hybridize to adjacent complementary primers 18 and are extended again to form two new double-stranded loops. The process is repeated for each template copy by cycles of isothermal denaturation and amplification to create a compact clonal cluster. Each cluster of double-stranded bridges is denatured. In one example, the reverse strand is removed by specific base cleavage, leaving the forward template polynucleotide strand. It should be understood that clustering results in the formation of several template sequenceable nucleic acid fragments in each lane 20 or well 32.

[0186] After cluster generation, the cationic moieties 16 can be cleaved from the cationic polymer hydrogel 14. Thus, the charge of the flow cell surface can be considered reversible. Cleavage of the cationic moieties 16 can be performed when the cationic moieties 16 are attached via a cleavable or cleavable linker 28, 28' (e.g., comprising a cleavable disulfide bond, or a photocleavable bond, or a cleavable nucleotide bond). Cleavage of the cationic moieties 16 can be achieved by photocleavage, by exposure to acidic conditions (e.g., when the linker is acid labile), or by enzymatic cleavage (e.g., when bifunctional DNA oligos are used as linkers 28, 28' to attach the cationic moieties 16). Cleavage of the cationic moieties 16 can reverse the charge of the flow cell surface, due in part to the negative charge of the template sequenceable nucleic acid fragments attached to the polymer hydrogel 14.

[0187] After cluster generation (and optionally after cleavage of cationic moieties 16), sequencing may be performed. Any of the examples of flow cells 10, 10', 10'' disclosed herein may be used in a variety of sequencing approaches or techniques, including techniques often referred to as sequencing by synthesis (SBS), circular array sequencing, sequencing by ligation, pyrosequencing, and the like.

[0188] As an example, sequencing by synthesis (SBS) can be performed on systems such as HISEQ™, HISEQX™, MISEQ™, MISEQDX™, MINISEQ™, NOVASEQ™, NEXTSEQDX™, ISEQ™, NEXTSEQ™, or other sequencer systems from ILLUMINa (SAN DIEGO, CA). In SBS, the extension of a sequencing primer along a template sequenceable nucleic acid fragment is monitored to determine the sequence of nucleotides in the template. The 3' end of the template and any flow cell-bound primer 18 (not attached to the copy) can be blocked to prevent interference with the sequencing reaction, particularly to prevent undesired priming. The underlying chemical process can be polymerization (e.g., catalyzed by a polymerase enzyme) or ligation (e.g., catalyzed by a ligase enzyme). In certain polymerase-based SBS processes, fluorescently labeled nucleotides are added to the sequencing primer in a template-dependent manner, such that detection of the order and type of nucleotides added to the sequencing primer can be used to determine the sequence of the template. For example, to initiate a first SBS cycle, one or more labeled nucleotides, a DNA polymerase, or the like, can be delivered into / through a flow cell 10, or the like, and extension of the sequencing primer incorporates a labeled nucleotide. This incorporation can be detected by an imaging event. During imaging, an illumination system (not shown) may provide excitation light to the flow cell 10, 10', 10''.

[0189] In some examples, the fluorescently labeled nucleotide can further include a reversible termination property that terminates further primer extension when the nucleotide is added to the template. For example, a nucleotide analog with a reversible terminator portion can be added to the template such that no further extension can occur until a deblocking agent is delivered to remove the portion. Thus, in examples using reversible termination, a deblocking reagent can be delivered to a flow cell, etc. (after detection has occurred).

[0190] Wash(es) may be performed between the various fluid delivery steps. The SBS cycle is then repeated n times to extend the template by n nucleotides, thereby allowing a sequence of length n to be detected.

[0191] Although SBS has been described in detail, it should be understood that the flow cells 10, 10', 10'' described herein may be utilized for genotyping or in other chemical and / or biological applications.

[0192] Other Flow Cell Applications

[0193] Although sequencing has been described in detail, it should be understood that the flow cells 10, 10', 10'' described herein may be utilized in other applications where a positively charged surface is desirable. As an example, the positively charged polymer hydrogel 14 may be suitable for extracting DNA from a lysate introduced into the flow cell 10, 10', 10''. For example, cells may be introduced into the lane(s) 20 or chamber 38, 38' and then a lysis buffer may be introduced. DNA released from the cells may be attracted to the positively charged surface. An external immobilizing agent (e.g., oil, air) may or may not be used to further help contain the extracted DNA.

[0194] As another example, a positively charged polymer hydrogel 14 can be used to repel proteins under certain pH conditions, thereby preventing undesirable protein binding at the surface. In these examples, the positively charged polymer hydrogel 14 may or may not have an amplification primer 18 attached to it.

[0195] The flow cells 10, 10', 10'' described herein may be utilized in other applications where a reversibly charged surface is desirable. The reversibly charged surface may be positively charged when the cationic moiety 16 is attached and negatively charged when the cationic moiety 16 is cleaved therefrom. The positively charged surface may help attract DNA and the negatively charged surface may aid in elution. A negatively charged surface may also be desirable to attract positively charged cells (e.g., bacteria) to the flow cell surface.

[0196] To further illustrate the present disclosure, examples are provided herein. It should be understood that the examples are provided for illustrative purposes and should not be construed as limiting the scope of the present disclosure. Non-limiting working examples

[0197] An exemplary flow cell lane and a comparative exemplary flow cell lane were prepared using a glass substrate with two lanes. Both lanes were silanized and PAZAM was deposited on them. P5 and P7 primers were then grafted onto the PAZAM in the lanes. A lid was attached to the substrate using a UV-curable adhesive to fluidically separate the two lanes.

[0198] Tris(hydropropyl)-phosphine (100 mM THP in 50 mM Tris-HCl buffer, pH 9) was introduced into the example lanes for approximately 2 minutes at 60° C. The other (comparison) lanes were not treated with the mixture.

[0199] The complex used in this example included a solid support and a sequenceable nucleic acid fragment attached to the solid support via an avidin-biotin linker. The library fragments of the complex were similar to those shown in FIG. 8B. A PCR-free library was prepared in a tube according to the TRUSEQ™ platform (Illumina, Inc.) protocol. The library was bound to the beads by hybridization to a P7 primer attached to the beads via biotin. The library was stained with Sytox green.

[0200] The complexes were introduced into the flow cell lanes of the examples and the comparative examples by flowing hybridization buffer (200 μL in hybridization buffer) containing the complexes through each of the lanes. Seeding was initiated by releasing the library fragments from the complexes. Library release was initiated by heating the flow cell above the melting temperature of the P7 primer. The fragments were hybridized and first strand extension was performed. The solid support and non-hybridized fragments were removed with 0.2 M NaOH solution. Clustering was then performed using bridge amplification.

[0201] After clustering, micrographs were taken of the lanes of the examples and comparisons, and the original staining was inverted for clarity. As shown in FIG. 9A, the comparative lane that was not treated with tris(hydropropyl)-phosphine had the library seeded relatively evenly across the surface, as evidenced by the diffuse darker spots in the inverted micrograph. FIG. 9B is a schematic of library release from the complex on the comparative flow cell lane. The figure shows the width of the lane, and the scale bar represents the actual dimensions of the field of view relative to the inner surface of the 2D flow cell. As shown in the diagram in FIG. 9B, library fragment transport and seeding are not restricted.

[0202] In contrast, as shown in FIG. 10A, the example lane (treated with tris(hydrapropyl)-phosphine) had a region of DNA library enrichment. The region was evidenced by the concentrated dark spots in the inverted micrograph. FIG. 10B is a schematic of library release from complexes on an exemplary flow cell lane. The figure shows the lane width, and the scale bar represents the actual dimensions of the field of view on the 2D flow cell inner surface. As shown in FIG. 10B, negatively charged library fragments are attracted to the positively charged flow cell surface, limiting library fragment transport and seeding. These results indicate that the tris(hydroxypropyl)-phosphine treated surface was positively charged and therefore could attract DNA library fragments upon release of the DNA library fragments from the complexes.

[0203] Additional Notes

[0204] Moreover, ranges provided herein should be understood to include the stated range and any value or subrange within the stated range, as if expressly recited. For example, a range expressed by about 2 mm to about 300 mm should be interpreted to include not only the explicitly recited limits of about 2 mm to about 300 mm, but also individual values ​​such as about 15 mm, 22.5 mm, 245 mm, and subranges such as about 20 mm to about 225 mm.

[0205] It should be understood that all combinations of the foregoing concepts and further concepts discussed in more detail below (provided that such concepts are not mutually inconsistent) are considered to be part of the inventive subject matter disclosed herein. In particular, all combinations of claimed subject matter appearing at the end of this disclosure are considered to be part of the inventive subject matter disclosed herein. It should also be understood that the terms expressly used herein and which may also appear in any disclosures incorporated by reference are to be given the meaning most consistent with the particular concepts disclosed herein.

[0206] Although several embodiments have been described in detail, it should be understood that the disclosed examples may be modified, and therefore the foregoing description should be considered as non-limiting.

Claims

1. A flow cell comprising: A substrate; a cationic polymer hydrogel on said substrate, said cationic polymer hydrogel comprising cationic moieties i) incorporated into monomer units of an initial polymer hydrogel or ii) attached to said monomer units of said initial polymer hydrogel via a linker; an amplification primer attached to the cationic polymer hydrogel; a flow cell comprising:

2. the monomer unit is N-(5-bromoacetamidylpentyl)acrylamide, the cationic moiety is a phosphonium cation; 2. The flow cell of claim 1, wherein the phosphonium cation replaces the bromine of N-(5-bromoacetamidylpentyl)acrylamide.

3. 3. The flow cell of claim 2, wherein the phosphonium cation is selected from the group consisting of tris(hydroxymethyl)phosphonium cation, tris(hydroxypropyl)phosphonium cation, tetrakis(hydroxymethyl)phosphonium cation, and tris(2-carboxyethyl)phosphonium cation.

4. i) the monomeric unit comprises a terminal azide group and the linker comprises an alkyne group; or ii) The flow cell of claim 1, wherein the monomer unit comprises a terminal alkyne group and the linker comprises an azide group.

5. 5. The flow cell of claim 4, wherein the cationic moieties comprise protonated amine groups, sulfonium ions, quaternary ammonium cations, or combinations thereof.

6. the monomer unit is N-(5-azidoacetamidylpentyl)acrylamide, The flow cell of claim 4, wherein the cationic moiety is an N,N,N-trimethylethanolammonium cation.

7. 5. The flow cell of claim 4, wherein the linker further comprises a cleavable disulfide bond, a photocleavable bond, a cleavable phosphodiester bond, or a combination thereof.

8. the monomer unit is N-(5-azidoacetamidylpentyl)acrylamide, the linker comprises a terminal alkyne group and a terminal bromine; 2. The flow cell of claim 1, wherein the cationic moiety is a phosphonium cation replacing the terminal bromine.

9. 10. The flow cell of claim 1, wherein the substrate comprises a plurality of recesses separated by intervening regions, the cationic polymer hydrogel being disposed within each of the recesses.

10. The flow cell of claim 9 , wherein the substrate further comprises a plurality of chambers, and a subset of the plurality of recesses is located within a perimeter of each of the plurality of chambers.

11. 1. A method comprising: a fluid comprising a positively charged moiety, an initial polymer hydrogel having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups; an amplification primer attached to the initial polymer hydrogel; and introducing into a flow cell comprising: incubating the initial polymer hydrogel in the fluid at a temperature for a period of time, thereby forming a cationic polymer hydrogel comprising cationic moieties; A method comprising:

12. The method of claim 11 , wherein the positively charged moieties replace the negatively charged atoms of the initial polymer hydrogel.

13. the surface moiety is the negatively charged atom, the negatively charged atom is bromine, The method of claim 12, wherein the positively charged moiety is selected from the group consisting of tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine, and tris(2-carboxyethyl)phosphine.

14. The method of claim 12, wherein the fluid further comprises a buffer having a pH in the range of 6 to 12.

15. 13. The method of claim 12, wherein the temperature ranges from 18°C ​​to 65°C and the time ranges from 1.5 minutes to 5 minutes.

16. the surface moiety is the azide group or the alkyne group; The method of claim 11 , wherein the positively charged moiety is covalently attached to the surface moiety via a linker.

17. the surface moiety is the azide group; the linker is an alkyne group, 17. The method of claim 16, wherein the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof.

18. the surface moiety is the alkyne group; the linker is an azide group; 17. The method of claim 16, wherein the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof.

19. 17. The method of claim 16, wherein a compound comprises the positively charged moiety attached to the linker, and the compound is propargylcholine bromide.

20. The method of claim 16 , wherein the fluid comprises water.

21. 17. The method of claim 16, wherein the temperature ranges from 18°C ​​to 60°C and the time ranges from 30 minutes to 12 hours.

22. 17. The method of claim 16, further comprising adding a catalyst, a ligand, and a reducing agent to the flow cell containing the fluid.

23. A substrate; an initial polymer hydrogel disposed on the substrate, the initial polymer hydrogel having surface moieties selected from the group consisting of negatively charged atoms, azide groups, and alkyne groups; an amplification primer attached to the initial polymer hydrogel; a fluid comprising positively charged moieties that interact or react with said surface moieties to form a cationic polymer hydrogel comprising said cationic moieties; A flow cell including A kit comprising:

Citation Information

Patent Citations

  • Protective surface coatings for flow cells

    WO2018208561A1

  • Flow cells with hydrogel coating

    WO2019126040A1